Biodegradable Adhesive Polymer Blends Prevent Surgical Adhesions

This polymer fiber technology provides a reliable solution to one of surgery’s most persistent challenges, minimizing postoperative adhesions and improving patient recovery.

Background

Post-surgical adhesions occur when tissue surfaces abnormally bind together due to inflammation, leading to pain, organ dysfunction, and increased surgical risks. Seprafilm, a widely used adhesion barrier, struggles with rapid degradation and poor tissue adhesion, often failing to prevent scar tissue formation. Many biodegradable polymers, such as poly(lactic-co-glycolic acid) (PLGA), lack the necessary balance between strength and controlled erosion, limiting their effectiveness. This new polymer solution directly addresses these challenges by combining optimal adhesion properties with sustained degradation kinetics.

Technology

A novel biodegradable polymer blend, poly(lactide-co-caprolactone) (PLCL), has been developed to function as an effective adhesion barrier. Unlike conventional materials, PLCL degrades through surface erosion rather than bulk degradation, allowing it to selectively dissolve scar tissue connections without causing excessive inflammation. The polymer is deposited using solution blow spinning (SBS), a technique that enables precise application of tissue-conforming scaffolds. By blending low-molecular-weight (LMW) PLCL for adhesion strength with high-molecular-weight (HMW) PLCL for mechanical stability, this innovation ensures a controlled, 14-day degradation rate that counteracts adhesion formation.

Benefits

  • Enhanced biocompatibility minimizing adverse tissue reactions
  • Tailorable degradation rates via PLGA/PEG ratio for controlled release
  • Incorporation of silica particles or drugs enables sustained therapeutic delivery
  • Robust polymer fiber constructs providing mechanical support for tissue engineering
  • Versatile fabrication methods compatible with various geometries and scales

Applications

  • Postoperative adhesion prevention in abdominal, gynecological, and orthopedic surgeries.
  • Tissue engineering and regenerative medicine to support healing and minimize fibrosis.
  • Biomedical sealant for surgical wounds to improve healing outcomes and reduce complications.

Additional info

A biocompatible solution blending low and high molecular weight polymers such as PLGA and PEG, optionally loaded with silica particles or therapeutic agents, is processed into fiber constructs via techniques like electrospinning. These polymeric fibers offer controlled release profiles, structural scaffolding for tissue engineering, and customizable degradation rates for implantable biomedical applications.

Publication

Erdi M, Rozyyev S, Balabhadrapatruni M, Saruwatari MS, Daristotle JL, Ayyub OB, Sandler AD, Kofinas P. “Sprayable tissue adhesive with biodegradation tuned for prevention of postoperative abdominal adhesions”. Bioeng Transl Med. 2022 May 23;8(1):e10335.